Werewolf Therapeutics (HOWL) Earnings Analysis
Werewolf Therapeutics (HOWL) next reports earnings on 2026-08-13, consensus EPS -0.28 USD. Last quarter (2026-05-07) it beat with EPS -0.28 USD vs -0.32 USD est (+12.5%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HOWL next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.28 USD |
| Revenue estimate | n/a |
HOWL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.28 USD | -0.32 USD | +12.5% | Beat |
| 2026-03-27 | -0.2 USD | -0.34 USD | +41.2% | Beat |
| 2025-08-14 | -0.4 USD | -0.5 USD | +20% | Beat |
| 2025-03-11 | -0.46 USD | -0.43 USD | -7% | Miss |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
HOWL valuation and analyst view
| Trailing P/E | -0.30 |
|---|---|
| Trailing EPS | -1.15779 USD |
| Price / book | 1.45 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (8 buy / 1 hold / 0 sell) |
| Avg price target | 1 USD |
Related research pages
Frequently asked questions
When is Werewolf Therapeutics (HOWL)'s next earnings date?
Werewolf Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.28 USD.
Did HOWL beat earnings last quarter?
In its 2026-05-07 report, HOWL posted EPS of -0.28 USD versus a -0.32 USD estimate — a beat of 12.5%.
What is HOWL's earnings track record?
Over the last 4 reported quarters with consensus data, HOWL beat estimates 3 times (75%).
What is HOWL's current P/E ratio and EPS?
HOWL trades at a trailing P/E of -0.30 on trailing EPS of -1.1577918776038356 USD.
What do analysts rate HOWL?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 1 USD.